Skip to content

Press Releases

July 24, 2023

Panbela Opens Enrollment in UK and Germany for Aspire Trial in Pancreatic Cancer

All Countries/Regions in the Aspire Trial are Now Open and Actively Enrolling

Interim Data Analysis anticipated in Early 2024

View/download press release »

Sign up to receive press releases via email